Articles
Allied's CardioCel stands the test of time
Allied Healthcare (ASX:AHZ) said paediatric heart defect patients treated using its CardioCel tissue patch have shown no sign of calcification at the site of repair after up to five years of monitoring. [ + ]
Lymphatic mispatterning
Natasha Harvey will head to ComBio this year with a few years’ worth of results and an exciting new story of a protein called Nedd4 and how it could hold a key to vascular networks and their problems. [ + ]
Innate Immunotherapeutics plans move across Tasman
New Zealand biopharmaceutical company Innate Immunotherapeutics will migrate across the Tasman this month in a bid to get its Phase IIb trial financed and underway in Australia. [ + ]
Insect resistance and transgenic crops
Many transgenic crops synthesise their own pesticides, usually a toxic protein is synthesised in stems and leaves. Pests attempting to eat the crop are killed while those not attacking the crop are completely unaffected. A pretty nifty solution but now examples are emerging of pests developing resistance to the toxin as a dominant trait. [ + ]
Why some people don't get as sick and a universal flu vaccine
Investigating why some people seem to resist severe illness has led scientists closer to developing a universal flu vaccine. [ + ]
Bioniche to raise $10m through equity offer
Bioniche (ASX:BNC) has launched a $10m capital raising in Canada to ensure it has funds to continue development of cancer treatment Urocidin while it sells its animal health unit. [ + ]
Viralytics meets primary goal of melanoma trial
A phase II trial of Viralytics' (ASX:VLA) Cavatak cancer-targeting virus in late-stage melanoma is still recruiting patients but has already met its primary endpoint. [ + ]
Be a part of the first Australian world brain mapping congress: call for papers and registrations open
For the first time in Australia, all disciplines involved in brain mapping and therapies will gather at the one conference when the 11th Annual World Congress of the Society for Brain Mapping and Therapeutics (SBMT Congress) comes to Sydney early next year. [ + ]
Microalgae, bacteria and a bioreactor
A solution to a major problem - arsenic poisoning from natural groundwater - may be within reach thanks to Australian research. [ + ]
SMART Arm wins CA grant for limb rehab device
Start-up SMART Arm will receive a grant worth $200K to help commercialise its eponymous upper limb rehabilitation device for stroke victims. [ + ]
Ig Nobel prize winners announced
They may make you laugh but the winners of this year's Ig Nobel prizes have all been published and contribute to the world's growing body of sometimes useless knowledge. [ + ]
New genes for an old breed
A new breeding technique and an old wheat cultivar are combining to produce quality wheat faster. [ + ]
Patrys antibody gets orphan drug status in myeloma
Patrys's (ASX:PAB) anticancer antibody, PAT-SM6, has been granted orphan drug designation in the EU for bone marrow cancer multiple myeloma. [ + ]
Starpharma developing new chemotherapy formulation
Starpharma (ASX:SPL) will advance dendrimer-oxaliplatin into development, after lab trials indicate its version of the chemotherapy drug can be more effective and reduces toxicity. [ + ]
Beaming up information with quantum teleportation
University of Queensland (UQ) physicists have successfully 'teleported' an atom, transmitting it from one location to another inside an electronic chip. This marks the first time quantum teleportation has been achieved in a solid-state system. [ + ]